Global Drug Discovery Services Market to Reach $61.1 Billion by 2030

2023-02-08

NEW YORK, Feb. 8, 2023 /PRNewswire/ -- The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia's war on Ukraine will play out this year and the war's role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Drug Discovery Services Market to Reach $61.1 Billion by 2030

Preview

来源: PRNewswire

Source: ReportLinker Research

Read the full report: https://www.reportlinker.com/p06031398/?utm_source=PRN

Global Drug Discovery Services Market to Reach $61.1 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Drug Discovery Services estimated at US$42.9 Billion in the year 2022, is projected to reach a revised size of US$61.1 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2022-2030. Medicinal Chemistry Services, one of the segments analyzed in the report, is projected to record a 5.3% CAGR and reach US$31.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Biology Services segment is readjusted to a revised 4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $11.5 Billion, While China is Forecast to Grow at 8.2% CAGR

The Drug Discovery Services market in the U.S. is estimated at US$11.5 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$14.1 Billion by the year 2030 trailing a CAGR of 8.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.9% and 2.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$9.1 Billion by the year 2030.

Select Competitors (Total 33 Featured)

- Albany Molecular Research Inc.

- Charles River Laboratories International Inc.

- Domainex

- Eurofins Scientific SE

- Evotec A.G.

- GenScript Biotech Corporation

- Jubilant Biosys Ltd.

- Laboratory Corporation of America Holdings

- Pharmaceutical Product Development LLC

- Piramal Enterprises Ltd.

- Selvita S.A.

- Thermo Fisher Scientific Inc.

- WuXi AppTec

Read the full report: https://www.reportlinker.com/p06031398/?utm_source=PRN

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights

World Market Trajectories

Impact of Covid-19 and a Looming Global Recession

Drug Discovery Services - Global Key Competitors Percentage

Market Share in 2022 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for

Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for Drug

Discovery Services by Geographic Region - USA, Canada, Japan,

China, Europe, Asia-Pacific, Latin America, Middle East and

Africa Markets - Independent Analysis of Annual Sales in US$

Million for Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for Drug Discovery Services by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 3: World 18-Year Perspective for Drug Discovery Services

by Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa Markets for Years 2012, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for

Medicinal Chemistry Services by Geographic Region - USA,

Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa Markets - Independent Analysis of Annual

Sales in US$ Million for Years 2022 through 2030 and % CAGR

Table 5: World Historic Review for Medicinal Chemistry Services

by Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 6: World 18-Year Perspective for Medicinal Chemistry

Services by Geographic Region - Percentage Breakdown of Value

Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,

Latin America, Middle East and Africa for Years 2012, 2023 &

2030

Table 7: World Recent Past, Current & Future Analysis for

Biology Services by Geographic Region - USA, Canada, Japan,

China, Europe, Asia-Pacific, Latin America, Middle East and

Africa Markets - Independent Analysis of Annual Sales in US$

Million for Years 2022 through 2030 and % CAGR

Table 8: World Historic Review for Biology Services by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 9: World 18-Year Perspective for Biology Services by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for Drug

Metabolism & Pharmacokinetics by Geographic Region - USA,

Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa Markets - Independent Analysis of Annual

Sales in US$ Million for Years 2022 through 2030 and % CAGR

Table 11: World Historic Review for Drug Metabolism &

Pharmacokinetics by Geographic Region - USA, Canada, Japan,

China, Europe, Asia-Pacific, Latin America, Middle East and

Africa Markets - Independent Analysis of Annual Sales in US$

Million for Years 2012 through 2021 and % CAGR

Table 12: World 18-Year Perspective for Drug Metabolism &

Pharmacokinetics by Geographic Region - Percentage Breakdown of

Value Sales for USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa for Years

2012, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for

Cardiovascular Diseases by Geographic Region - USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa Markets - Independent Analysis of Annual Sales in

US$ Million for Years 2022 through 2030 and % CAGR

Table 14: World Historic Review for Cardiovascular Diseases by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 15: World 18-Year Perspective for Cardiovascular Diseases

by Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for

Other Therapeutic Areas by Geographic Region - USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa Markets - Independent Analysis of Annual Sales in

US$ Million for Years 2022 through 2030 and % CAGR

Table 17: World Historic Review for Other Therapeutic Areas by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 18: World 18-Year Perspective for Other Therapeutic Areas

by Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for

Oncology by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2022 through 2030 and % CAGR

Table 20: World Historic Review for Oncology by Geographic

Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin

America, Middle East and Africa Markets - Independent Analysis

of Annual Sales in US$ Million for Years 2012 through 2021 and

% CAGR

Table 21: World 18-Year Perspective for Oncology by Geographic

Region - Percentage Breakdown of Value Sales for USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa for Years 2012, 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for

Neurology by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2022 through 2030 and % CAGR

Table 23: World Historic Review for Neurology by Geographic

Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin

America, Middle East and Africa Markets - Independent Analysis

of Annual Sales in US$ Million for Years 2012 through 2021 and

% CAGR

Table 24: World 18-Year Perspective for Neurology by Geographic

Region - Percentage Breakdown of Value Sales for USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa for Years 2012, 2023 & 2030

Table 25: World Recent Past, Current & Future Analysis for

Infectious & Immune System Diseases by Geographic Region - USA,

Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa Markets - Independent Analysis of Annual

Sales in US$ Million for Years 2022 through 2030 and % CAGR

Table 26: World Historic Review for Infectious & Immune System

Diseases by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2012 through 2021 and % CAGR

Table 27: World 18-Year Perspective for Infectious & Immune

System Diseases by Geographic Region - Percentage Breakdown of

Value Sales for USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa for Years

2012, 2023 & 2030

Table 28: World Recent Past, Current & Future Analysis for

Digestive System Diseases by Geographic Region - USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa Markets - Independent Analysis of Annual Sales in

US$ Million for Years 2022 through 2030 and % CAGR

Table 29: World Historic Review for Digestive System Diseases

by Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 30: World 18-Year Perspective for Digestive System

Diseases by Geographic Region - Percentage Breakdown of Value

Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,

Latin America, Middle East and Africa for Years 2012, 2023 &

2030

Table 31: World Recent Past, Current & Future Analysis for

Small Molecules by Geographic Region - USA, Canada, Japan,

China, Europe, Asia-Pacific, Latin America, Middle East and

Africa Markets - Independent Analysis of Annual Sales in US$

Million for Years 2022 through 2030 and % CAGR

Table 32: World Historic Review for Small Molecules by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 33: World 18-Year Perspective for Small Molecules by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2023 & 2030

Table 34: World Recent Past, Current & Future Analysis for

Biologics by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2022 through 2030 and % CAGR

Table 35: World Historic Review for Biologics by Geographic

Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin

America, Middle East and Africa Markets - Independent Analysis

of Annual Sales in US$ Million for Years 2012 through 2021 and

% CAGR

Table 36: World 18-Year Perspective for Biologics by Geographic

Region - Percentage Breakdown of Value Sales for USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa for Years 2012, 2023 & 2030

Table 37: World Drug Discovery Services Market Analysis of

Annual Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

UNITED STATES

Drug Discovery Services Market Presence - Strong/Active/Niche/

Trivial - Key Competitors in the United States for 2023 (E)

Table 38: USA Recent Past, Current & Future Analysis for Drug

Discovery Services by Type - Medicinal Chemistry Services,

Biology Services and Drug Metabolism & Pharmacokinetics -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 39: USA Historic Review for Drug Discovery Services by

Type - Medicinal Chemistry Services, Biology Services and Drug

Metabolism & Pharmacokinetics Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 40: USA 18-Year Perspective for Drug Discovery Services

by Type - Percentage Breakdown of Value Sales for Medicinal

Chemistry Services, Biology Services and Drug Metabolism &

Pharmacokinetics for the Years 2012, 2023 & 2030

Table 41: USA Recent Past, Current & Future Analysis for Drug

Discovery Services by Therapeutic Area - Cardiovascular

Diseases, Other Therapeutic Areas, Oncology, Neurology,

Infectious & Immune System Diseases and Digestive System

Diseases - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 42: USA Historic Review for Drug Discovery Services by

Therapeutic Area - Cardiovascular Diseases, Other Therapeutic

Areas, Oncology, Neurology, Infectious & Immune System Diseases

and Digestive System Diseases Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 43: USA 18-Year Perspective for Drug Discovery Services

by Therapeutic Area - Percentage Breakdown of Value Sales for

Cardiovascular Diseases, Other Therapeutic Areas, Oncology,

Neurology, Infectious & Immune System Diseases and Digestive

System Diseases for the Years 2012, 2023 & 2030

Table 44: USA Recent Past, Current & Future Analysis for Drug

Discovery Services by Drug Type - Small Molecules and Biologics -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 45: USA Historic Review for Drug Discovery Services by

Drug Type - Small Molecules and Biologics Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2012 through

2021 and % CAGR

Table 46: USA 18-Year Perspective for Drug Discovery Services

by Drug Type - Percentage Breakdown of Value Sales for Small

Molecules and Biologics for the Years 2012, 2023 & 2030

CANADA

Table 47: Canada Recent Past, Current & Future Analysis for

Drug Discovery Services by Type - Medicinal Chemistry Services,

Biology Services and Drug Metabolism & Pharmacokinetics -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 48: Canada Historic Review for Drug Discovery Services by

Type - Medicinal Chemistry Services, Biology Services and Drug

Metabolism & Pharmacokinetics Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 49: Canada 18-Year Perspective for Drug Discovery

Services by Type - Percentage Breakdown of Value Sales for

Medicinal Chemistry Services, Biology Services and Drug

Metabolism & Pharmacokinetics for the Years 2012, 2023 & 2030

Table 50: Canada Recent Past, Current & Future Analysis for

Drug Discovery Services by Therapeutic Area - Cardiovascular

Diseases, Other Therapeutic Areas, Oncology, Neurology,

Infectious & Immune System Diseases and Digestive System

Diseases - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 51: Canada Historic Review for Drug Discovery Services by

Therapeutic Area - Cardiovascular Diseases, Other Therapeutic

Areas, Oncology, Neurology, Infectious & Immune System Diseases

and Digestive System Diseases Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 52: Canada 18-Year Perspective for Drug Discovery

Services by Therapeutic Area - Percentage Breakdown of Value

Sales for Cardiovascular Diseases, Other Therapeutic Areas,

Oncology, Neurology, Infectious & Immune System Diseases and

Digestive System Diseases for the Years 2012, 2023 & 2030

Table 53: Canada Recent Past, Current & Future Analysis for

Drug Discovery Services by Drug Type - Small Molecules and

Biologics - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 54: Canada Historic Review for Drug Discovery Services by

Drug Type - Small Molecules and Biologics Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2012 through

2021 and % CAGR

Table 55: Canada 18-Year Perspective for Drug Discovery

Services by Drug Type - Percentage Breakdown of Value Sales for

Small Molecules and Biologics for the Years 2012, 2023 & 2030

JAPAN

Drug Discovery Services Market Presence - Strong/Active/Niche/

Trivial - Key Competitors in Japan for 2023 (E)

Table 56: Japan Recent Past, Current & Future Analysis for Drug

Discovery Services by Type - Medicinal Chemistry Services,

Biology Services and Drug Metabolism & Pharmacokinetics -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 57: Japan Historic Review for Drug Discovery Services by

Type - Medicinal Chemistry Services, Biology Services and Drug

Metabolism & Pharmacokinetics Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 58: Japan 18-Year Perspective for Drug Discovery Services

by Type - Percentage Breakdown of Value Sales for Medicinal

Chemistry Services, Biology Services and Drug Metabolism &

Pharmacokinetics for the Years 2012, 2023 & 2030

Table 59: Japan Recent Past, Current & Future Analysis for Drug

Discovery Services by Therapeutic Area - Cardiovascular

Diseases, Other Therapeutic Areas, Oncology, Neurology,

Infectious & Immune System Diseases and Digestive System

Diseases - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 60: Japan Historic Review for Drug Discovery Services by

Therapeutic Area - Cardiovascular Diseases, Other Therapeutic

Areas, Oncology, Neurology, Infectious & Immune System Diseases

and Digestive System Diseases Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 61: Japan 18-Year Perspective for Drug Discovery Services

by Therapeutic Area - Percentage Breakdown of Value Sales for

Cardiovascular Diseases, Other Therapeutic Areas, Oncology,

Neurology, Infectious & Immune System Diseases and Digestive

System Diseases for the Years 2012, 2023 & 2030

Table 62: Japan Recent Past, Current & Future Analysis for Drug

Discovery Services by Drug Type - Small Molecules and Biologics -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 63: Japan Historic Review for Drug Discovery Services by

Drug Type - Small Molecules and Biologics Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2012 through

2021 and % CAGR

Table 64: Japan 18-Year Perspective for Drug Discovery Services

by Drug Type - Percentage Breakdown of Value Sales for Small

Molecules and Biologics for the Years 2012, 2023 & 2030

CHINA

Drug Discovery Services Market Presence - Strong/Active/Niche/

Trivial - Key Competitors in China for 2023 (E)

Table 65: China Recent Past, Current & Future Analysis for Drug

Discovery Services by Type - Medicinal Chemistry Services,

Biology Services and Drug Metabolism & Pharmacokinetics -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 66: China Historic Review for Drug Discovery Services by

Type - Medicinal Chemistry Services, Biology Services and Drug

Metabolism & Pharmacokinetics Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 67: China 18-Year Perspective for Drug Discovery Services

by Type - Percentage Breakdown of Value Sales for Medicinal

Chemistry Services, Biology Services and Drug Metabolism &

Pharmacokinetics for the Years 2012, 2023 & 2030

Table 68: China Recent Past, Current & Future Analysis for Drug

Discovery Services by Therapeutic Area - Cardiovascular

Diseases, Other Therapeutic Areas, Oncology, Neurology,

Infectious & Immune System Diseases and Digestive System

Diseases - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 69: China Historic Review for Drug Discovery Services by

Therapeutic Area - Cardiovascular Diseases, Other Therapeutic

Areas, Oncology, Neurology, Infectious & Immune System Diseases

and Digestive System Diseases Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 70: China 18-Year Perspective for Drug Discovery Services

by Therapeutic Area - Percentage Breakdown of Value Sales for

Cardiovascular Diseases, Other Therapeutic Areas, Oncology,

Neurology, Infectious & Immune System Diseases and Digestive

System Diseases for the Years 2012, 2023 & 2030

Table 71: China Recent Past, Current & Future Analysis for Drug

Discovery Services by Drug Type - Small Molecules and Biologics -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 72: China Historic Review for Drug Discovery Services by

Drug Type - Small Molecules and Biologics Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2012 through

2021 and % CAGR

Table 73: China 18-Year Perspective for Drug Discovery Services

by Drug Type - Percentage Breakdown of Value Sales for Small

Molecules and Biologics for the Years 2012, 2023 & 2030

EUROPE

Drug Discovery Services Market Presence - Strong/Active/Niche/

Trivial - Key Competitors in Europe for 2023 (E)

Table 74: Europe Recent Past, Current & Future Analysis for

Drug Discovery Services by Geographic Region - France, Germany,

Italy, UK, Spain, Russia and Rest of Europe Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2022 through 2030 and % CAGR

Table 75: Europe Historic Review for Drug Discovery Services by

Geographic Region - France, Germany, Italy, UK, Spain, Russia

and Rest of Europe Markets - Independent Analysis of Annual

Sales in US$ Million for Years 2012 through 2021 and % CAGR

Table 76: Europe 18-Year Perspective for Drug Discovery

Services by Geographic Region - Percentage Breakdown of Value

Sales for France, Germany, Italy, UK, Spain, Russia and Rest of

Europe Markets for Years 2012, 2023 & 2030

Table 77: Europe Recent Past, Current & Future Analysis for

Drug Discovery Services by Type - Medicinal Chemistry Services,

Biology Services and Drug Metabolism & Pharmacokinetics -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 78: Europe Historic Review for Drug Discovery Services by

Type - Medicinal Chemistry Services, Biology Services and Drug

Metabolism & Pharmacokinetics Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 79: Europe 18-Year Perspective for Drug Discovery

Services by Type - Percentage Breakdown of Value Sales for

Medicinal Chemistry Services, Biology Services and Drug

Metabolism & Pharmacokinetics for the Years 2012, 2023 & 2030

Table 80: Europe Recent Past, Current & Future Analysis for

Drug Discovery Services by Therapeutic Area - Cardiovascular

Diseases, Other Therapeutic Areas, Oncology, Neurology,

Infectious & Immune System Diseases and Digestive System

Diseases - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 81: Europe Historic Review for Drug Discovery Services by

Therapeutic Area - Cardiovascular Diseases, Other Therapeutic

Areas, Oncology, Neurology, Infectious & Immune System Diseases

and Digestive System Diseases Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 82: Europe 18-Year Perspective for Drug Discovery

Services by Therapeutic Area - Percentage Breakdown of Value

Sales for Cardiovascular Diseases, Other Therapeutic Areas,

Oncology, Neurology, Infectious & Immune System Diseases and

Digestive System Diseases for the Years 2012, 2023 & 2030

Table 83: Europe Recent Past, Current & Future Analysis for

Drug Discovery Services by Drug Type - Small Molecules and

Biologics - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 84: Europe Historic Review for Drug Discovery Services by

Drug Type - Small Molecules and Biologics Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2012 through

2021 and % CAGR

Table 85: Europe 18-Year Perspective for Drug Discovery

Services by Drug Type - Percentage Breakdown of Value Sales for

Small Molecules and Biologics for the Years 2012, 2023 & 2030

FRANCE

Drug Discovery Services Market Presence - Strong/Active/Niche/

Trivial - Key Competitors in France for 2023 (E)

Table 86: France Recent Past, Current & Future Analysis for

Drug Discovery Services by Type - Medicinal Chemistry Services,

Biology Services and Drug Metabolism & Pharmacokinetics -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 87: France Historic Review for Drug Discovery Services by

Type - Medicinal Chemistry Services, Biology Services and Drug

Metabolism & Pharmacokinetics Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 88: France 18-Year Perspective for Drug Discovery

Services by Type - Percentage Breakdown of Value Sales for

Medicinal Chemistry Services, Biology Services and Drug

Metabolism & Pharmacokinetics for the Years 2012, 2023 & 2030

Table 89: France Recent Past, Current & Future Analysis for

Drug Discovery Services by Therapeutic Area - Cardiovascular

Diseases, Other Therapeutic Areas, Oncology, Neurology,

Infectious & Immune System Diseases and Digestive System

Diseases - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 90: France Historic Review for Drug Discovery Services by

Therapeutic Area - Cardiovascular Diseases, Other Therapeutic

Areas, Oncology, Neurology, Infectious & Immune System Diseases

and Digestive System Diseases Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 91: France 18-Year Perspective for Drug Discovery

Services by Therapeutic Area - Percentage Breakdown of Value

Sales for Cardiovascular Diseases, Other Therapeutic Areas,

Oncology, Neurology, Infectious & Immune System Diseases and

Digestive System Diseases for the Years 2012, 2023 & 2030

Table 92: France Recent Past, Current & Future Analysis for

Drug Discovery Services by Drug Type - Small Molecules and

Biologics - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 93: France Historic Review for Drug Discovery Services by

Drug Type - Small Molecules and Biologics Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2012 through

2021 and % CAGR

Table 94: France 18-Year Perspective for Drug Discovery

Services by Drug Type - Percentage Breakdown of Value Sales for

Small Molecules and Biologics for the Years 2012, 2023 & 2030

GERMANY

Drug Discovery Services Market Presence - Strong/Active/Niche/

Trivial - Key Competitors in Germany for 2023 (E)

Table 95: Germany Recent Past, Current & Future Analysis for

Drug Discovery Services by Type - Medicinal Chemistry Services,

Biology Services and Drug Metabolism & Pharmacokinetics -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 96: Germany Historic Review for Drug Discovery Services

by Type - Medicinal Chemistry Services, Biology Services and

Drug Metabolism & Pharmacokinetics Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2012 through

2021 and % CAGR

Table 97: Germany 18-Year Perspective for Drug Discovery

Services by Type - Percentage Breakdown of Value Sales for

Medicinal Chemistry Services, Biology Services and Drug

Metabolism & Pharmacokinetics for the Years 2012, 2023 & 2030

Table 98: Germany Recent Past, Current & Future Analysis for

Drug Discovery Services by Therapeutic Area - Cardiovascular

Diseases, Other Therapeutic Areas, Oncology, Neurology,

Infectious & Immune System Diseases and Digestive System

Diseases - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 99: Germany Historic Review for Drug Discovery Services

by Therapeutic Area - Cardiovascular Diseases, Other

Therapeutic Areas, Oncology, Neurology, Infectious & Immune

System Diseases and Digestive System Diseases Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 100: Germany 18-Year Perspective for Drug Discovery

Services by Therapeutic Area - Percentage Breakdown of Value

Sales for Cardiovascular Diseases, Other Therapeutic Areas,

Oncology, Neurology, Infectious & Immune System Diseases and

Digestive System Diseases for the Years 2012, 2023 & 2030

Table 101: Germany Recent Past, Current & Future Analysis for

Drug Discovery Services by Drug Type - Small Molecules and

Biologics - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 102: Germany Historic Review for Drug Discovery Services

by Drug Type - Small Molecules and Biologics Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 103: Germany 18-Year Perspective for Drug Discovery

Services by Drug Type - Percentage Breakdown of Value Sales for

Small Molecules and Biologics for the Years 2012, 2023 & 2030

ITALY

Table 104: Italy Recent Past, Current & Future Analysis for

Drug Discovery Services by Type - Medicinal Chemistry Services,

Biology Services and Drug Metabolism & Pharmacokinetics -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 105: Italy Historic Review for Drug Discovery Services by

Type - Medicinal Chemistry Services, Biology Services and Drug

Metabolism & Pharmacokinetics Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 106: Italy 18-Year Perspective for Drug Discovery

Services by Type - Percentage Breakdown of Value Sales for

Medicinal Chemistry Services, Biology Services and Drug

Metabolism & Pharmacokinetics for the Years 2012, 2023 & 2030

Table 107: Italy Recent Past, Current & Future Analysis for

Drug Discovery Services by Therapeutic Area - Cardiovascular

Diseases, Other Therapeutic Areas, Oncology, Neurology,

Infectious & Immune System Diseases and Digestive System

Diseases - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 108: Italy Historic Review for Drug Discovery Services by

Therapeutic Area - Cardiovascular Diseases, Other Therapeutic

Areas, Oncology, Neurology, Infectious & Immune System Diseases

and Digestive System Diseases Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 109: Italy 18-Year Perspective for Drug Discovery

Services by Therapeutic Area - Percentage Breakdown of Value

Sales for Cardiovascular Diseases, Other Therapeutic Areas,

Oncology, Neurology, Infectious & Immune System Diseases and

Digestive System Diseases for the Years 2012, 2023 & 2030

Table 110: Italy Recent Past, Current & Future Analysis for

Drug Discovery Services by Drug Type - Small Molecules and

Biologics - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 111: Italy Historic Review for Drug Discovery Services by

Drug Type - Small Molecules and Biologics Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2012 through

2021 and % CAGR

Table 112: Italy 18-Year Perspective for Drug Discovery

Services by Drug Type - Percentage Breakdown of Value Sales for

Small Molecules and Biologics for the Years 2012, 2023 & 2030

UNITED KINGDOM

Drug Discovery Services Market Presence - Strong/Active/Niche/

Trivial - Key Competitors in the United Kingdom for 2023 (E)

Table 113: UK Recent Past, Current & Future Analysis for Drug

Discovery Services by Type - Medicinal Chemistry Services,

Biology Services and Drug Metabolism & Pharmacokinetics -

Independent Analysis of Annual Sales in US$ Million for the

Years 2022 through 2030 and % CAGR

Table 114: UK Historic Review for Drug Discovery Services by

Type - Medicinal Chemistry Services, Biology Services and Drug

Metabolism & Pharmacokinetics Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 115: UK 18-Year Perspective for Drug Discovery Services

by Type - Percentage Breakdown of Value Sales for Medicinal

Chemistry Services, Biology Services and Drug Metabolism &

Pharmacokinetics for the Years 2012, 2023 & 2030

Table 116: UK Recent Past, Current & Future Analysis for Drug

Discovery Services by Therapeutic Area - Cardiovascular

Diseases, Other Therapeutic Areas, Oncology, Neurology,

Infectious & Immune System Diseases and Digestive System

Please contact our Customer Support Center to get the complete Table of Contents

Read the full report: https://www.reportlinker.com/p06031398/?utm_source=PRN

About Reportlinker

ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Contact Clare: [email protected]

US: (339)-368-6001

Intl: +1 339-368-6001

SOURCE Reportlinker